4//SEC Filing
LINNIK MATTHEW D 4
Accession 0001209191-03-022314
CIK 0000920465other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 6:02 PM ET
Size
9.9 KB
Accession
0001209191-03-022314
Insider Transaction Report
Form 4
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Award
Stock Options (right to buy)
2003-09-18$4.71/sh+60,338$284,192→ 669,000 totalExercise: $4.71Exp: 2013-09-18→ Common Stock (60,338 underlying) - Other
Common Stock
2003-06-30$1.48/sh+498$737→ 1,825 total - Award
Stock Options (right to buy)
2003-09-18$4.71/sh+14,662$69,058→ 608,662 totalExercise: $4.71Exp: 2013-09-18→ Common Stock (14,662 underlying)
Footnotes (2)
- [F1]Acquired pursuant to the Company???s Employee Stock Purchase Plan.
- [F2]The stock options vest and become exercisable monthly over the next three years.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237521
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 6:02 PM ET
- Size
- 9.9 KB